{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:54:44Z","timestamp":1759056884686},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,4,11]],"date-time":"2007-04-11T00:00:00Z","timestamp":1176249600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic>Streptococcus (S.) pneumoniae<\/jats:italic>meningitis has a high lethality despite antibiotic treatment. Inflammation is a major pathogenetic factor, which is unresponsive to antibiotics. Therefore adjunctive therapies with antiinflammatory compounds have been developed. TNF484 is a TNF-alpha converting enzyme (TACE) inhibitor and has been found efficacious in experimental meningitis. Toll-like receptor 2 (TLR2) contributes to host response in pneumococcal meningitis by enhancing bacterial clearing and downmodulating inflammation. In this study, TNF484 was applied in mice, which lacked TLR2 and exhibited a strong meningeal inflammation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>10<jats:sup>3<\/jats:sup>CFU<jats:italic>S. pneumoniae<\/jats:italic>serotype 3 was inoculated subarachnoidally into C57BL\/6 wild type (wt) mice or TLR2<jats:sup>-\/-<\/jats:sup>, CD14<jats:sup>-\/-<\/jats:sup>and CD14<jats:sup>-\/-<\/jats:sup>\/TLR2<jats:sup>-\/-<\/jats:sup>mice. Severity of disease and survival was followed over 9 days. Response to antibiotics (80 mg\/kg ceftriaxone i.p. for 5 days) and\/or TACE inhibitor treatment (1 mg\/kg s.c. twice daily for 4 days) was evaluated. Animals were sacrificed after 12, 24, and 48 h for analysis of bacterial load in cerebrospinal fluid (CSF) and brain and for TNF and leukocyte measurements in CSF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>TLR2<jats:sup>-\/-<\/jats:sup>mice were significantly sicker than the other mouse strains 24 h after infection. All knockout mice showed higher disease severity after 48 h and died earlier than wt mice. TNF release into CSF was significantly more elevated in TLR2<jats:sup>-\/-<\/jats:sup>than in the other strains after 24 h. Brain bacterial numbers were significantly higher in all knockout than wt mice after 24 h. Modulation of outcome by antibiotic and TACE inhibitor treatment was evaluated. With antibiotic therapy all wt, CD14<jats:sup>-\/-<\/jats:sup>and TLR2<jats:sup>-\/-<\/jats:sup>\/CD14<jats:sup>-\/-<\/jats:sup>mice, but only 79% of TLR2<jats:sup>-\/-<\/jats:sup>mice, were rescued. TACE inhibitor treatment alone did not rescue, but prolonged survival in wt mice, and in TLR2<jats:sup>-\/-<\/jats:sup>and CD14<jats:sup>-\/-<\/jats:sup>mice to the values observed in untreated wt mice. By combined antibiotic and TACE inhibitor treatment 95% of TLR2<jats:sup>-\/-<\/jats:sup>mice were rescued.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>During pneumococcal meningitis strong inflammation in TLR2-deficiency was associated with incomplete responsiveness to antibiotics and complete response to combined antibiotic and TACE inhibitor treatment. TACE inhibitor treatment offers a promising adjuvant therapeutic strategy in pneumococcal meningitis.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2334-7-25","type":"journal-article","created":{"date-parts":[[2007,5,2]],"date-time":"2007-05-02T15:25:24Z","timestamp":1178119524000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Adjuvant TACE inhibitor treatment improves the outcome of TLR2-\/-mice with experimental pneumococcal meningitis"],"prefix":"10.1186","volume":"7","author":[{"given":"Hakim","family":"Echchannaoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen L","family":"Leib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regine MA","family":"Landmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,11]]},"reference":[{"issue":"14","key":"468_CR1","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1056\/NEJM199710023371404","volume":"337","author":"A Schuchat","year":"1997","unstructured":"Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, Lefkowitz L, Perkins BA: Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med. 1997, 337 (14): 970-976. 10.1056\/NEJM199710023371404.","journal-title":"N Engl J Med"},{"key":"468_CR2","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.1086\/344939","volume":"186 Suppl 2","author":"WM Scheld","year":"2002","unstructured":"Scheld WM, Koedel U, Nathan B, Pfister HW: Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis. 2002, 186 Suppl 2: S225-33. 10.1086\/344939.","journal-title":"J Infect Dis"},{"issue":"12","key":"468_CR3","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S1473-3099(02)00450-4","volume":"2","author":"U Koedel","year":"2002","unstructured":"Koedel U, Scheld WM, Pfister HW: Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis. 2002, 2 (12): 721-736. 10.1016\/S1473-3099(02)00450-4.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"468_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2174\/1568005043340579","volume":"4","author":"V Pomar","year":"2004","unstructured":"Pomar V, Martinez S, Paredes R, Domingo P: Advances in adjuvant therapy against acute bacterial meningitis. Curr Drug Targets Infect Disord. 2004, 4 (4): 303-309. 10.2174\/1568005043340579.","journal-title":"Curr Drug Targets Infect Disord"},{"issue":"3","key":"468_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1203\/01.PDR.0000079185.67878.72","volume":"54","author":"SL Leib","year":"2003","unstructured":"Leib SL, Heimgartner C, Bifrare YD, Loeffler JM, Taauber MG: Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats. Pediatr Res. 2003, 54 (3): 353-357. 10.1203\/01.PDR.0000079185.67878.72.","journal-title":"Pediatr Res"},{"issue":"6","key":"468_CR6","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1086\/342845","volume":"186","author":"H Echchannaoui","year":"2002","unstructured":"Echchannaoui H, Frei K, Schnell C, Leib S, Zimmerli W, Landmann R: Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis due to reduced bacterial clearing and enhanced inflammation. J Infect Dis. 2002, 186 (6): 798-806. 10.1086\/342845.","journal-title":"J Infect Dis"},{"issue":"Pt 9","key":"468_CR7","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/brain\/124.9.1734","volume":"124","author":"SL Leib","year":"2001","unstructured":"Leib SL, Clements JM, Lindberg RL, Heimgartner C, Loeffler JM, Pfister LA, Tauber MG, Leppert D: Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain. 2001, 124 (Pt 9): 1734-1742. 10.1093\/brain\/124.9.1734.","journal-title":"Brain"},{"issue":"2","key":"468_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1128\/IAI.68.2.615-620.2000","volume":"68","author":"SL Leib","year":"2000","unstructured":"Leib SL, Leppert D, Clements J, Tauber MG: Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun. 2000, 68 (2): 615-620. 10.1128\/IAI.68.2.615-620.2000.","journal-title":"Infect Immun"},{"issue":"3","key":"468_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/00001432-200206000-00007","volume":"15","author":"DN Meli","year":"2002","unstructured":"Meli DN, Christen S, Leib SL, Tauber MG: Current concepts in the pathogenesis of meningitis caused by Streptococcus pneumoniae. Curr Opin Infect Dis. 2002, 15 (3): 253-257.","journal-title":"Curr Opin Infect Dis"},{"issue":"11","key":"468_CR10","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1021\/jm0110993","volume":"45","author":"G Kottirsch","year":"2002","unstructured":"Kottirsch G, Koch G, Feifel R, Neumann U: Beta-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme. J Med Chem. 2002, 45 (11): 2289-2293. 10.1021\/jm0110993.","journal-title":"J Med Chem"},{"issue":"12","key":"468_CR11","doi-asserted-by":"publisher","first-page":"8397","DOI":"10.1128\/IAI.73.12.8397-8401.2005","volume":"73","author":"M Letiembre","year":"2005","unstructured":"Letiembre M, Echchannaoui H, Bachmann P, Ferracin F, C. N, Espinosa M, Landmann R: TLR2 deficiency delays pneumococcal phagocytosis and impairs oxidative killing by granulocytes 2. Infect Immun. 2005, 73 (12): 8397-401.","journal-title":"Infect Immun"},{"issue":"5428","key":"468_CR12","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1126\/science.285.5428.732","volume":"285","author":"HD Brightbill","year":"1999","unstructured":"Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, Brennan PJ, Bloom BR, Godowski PJ, Modlin RL: Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science. 1999, 285 (5428): 732-736. 10.1126\/science.285.5428.732.","journal-title":"Science"},{"issue":"25","key":"468_CR13","doi-asserted-by":"publisher","first-page":"17406","DOI":"10.1074\/jbc.274.25.17406","volume":"274","author":"R Schwandner","year":"1999","unstructured":"Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ: Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem. 1999, 274 (25): 17406-17409. 10.1074\/jbc.274.25.17406.","journal-title":"J Biol Chem"},{"issue":"1","key":"468_CR14","doi-asserted-by":"publisher","first-page":"438","DOI":"10.4049\/jimmunol.170.1.438","volume":"170","author":"U Koedel","year":"2003","unstructured":"Koedel U, Angele B, Rupprecht T, Wagner H, Roggenkamp A, Pfister HW, Kirschning CJ: Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J Immunol. 2003, 170 (1): 438-444.","journal-title":"J Immunol"},{"key":"468_CR15","volume-title":"J Neuroimmunol","author":"M Letiembre","year":"2005","unstructured":"Letiembre M, Echchannaoui H, Ferracin F, Rivest S, Landmann R: Toll-like receptor-2 deficiency is associated with enhanced brain TNF gene expression during pneumococcal meningitis. J Neuroimmunol. 2005"},{"issue":"15","key":"468_CR16","doi-asserted-by":"publisher","first-page":"8680","DOI":"10.1074\/jbc.273.15.8680","volume":"273","author":"R Dziarski","year":"1998","unstructured":"Dziarski R, Tapping RI, Tobias PS: Binding of bacterial peptidoglycan to CD14. J Biol Chem. 1998, 273 (15): 8680-8690. 10.1074\/jbc.273.15.8680.","journal-title":"J Biol Chem"},{"key":"468_CR17","first-page":"463","volume-title":"Endotoxin in Health and DIsease","author":"AJ Ulmer","year":"1999","unstructured":"Ulmer AJ, Salmalouti V, Rietschel ET, Flad HD, Dziarsky R: CD14, an innate immune receptor for various bacterial cell wall components. Endotoxin in Health and DIsease. Edited by: Brade H, Opal S, Vogel S, Morrison D. 1999, New York , Dekker, 1: 463-471."},{"issue":"3","key":"468_CR18","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1189\/jlb.0205063","volume":"78","author":"H Echchannaoui","year":"2005","unstructured":"Echchannaoui H, Frei K, Letiembre M, Strieter RM, Adachi Y, Landmann R: CD14 deficiency leads to increased MIP-2 production, CXCR2 expression, neutrophil transmigration, and early death in pneumococcal infection. J Leukoc Biol. 2005, 78 (3): 705-715. 10.1189\/jlb.0205063.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"468_CR19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/1521-4141(200203)32:3<761::AID-IMMU761>3.0.CO;2-5","volume":"32","author":"T Merlin","year":"2002","unstructured":"Merlin T, Woelky-Bruggmann R, Fearns C, Freudenberg M, Landmann R: Expression and role of CD14 in mice sensitized to lipopolysaccharide by Propionibacterium acnes. Eur J Immunol. 2002, 32 (3): 761-772. 10.1002\/1521-4141(200203)32:3<761::AID-IMMU761>3.0.CO;2-5.","journal-title":"Eur J Immunol"},{"issue":"8","key":"468_CR20","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.4049\/jimmunol.162.8.4762","volume":"162","author":"A Cauwels","year":"1999","unstructured":"Cauwels A, Frei K, Sansano S, Fearns C, Ulevitch R, Zimmerli W, Landmann R: The origin and function of soluble CD14 in experimental bacterial meningitis. J Immunol. 1999, 162 (8): 4762-4772.","journal-title":"J Immunol"},{"issue":"3","key":"468_CR21","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/eji.200425336","volume":"35","author":"M Manukyan","year":"2005","unstructured":"Manukyan M, Triantafilou K, Triantafilou M, Mackie A, Nilsen N, Espevik T, Wiesmuller KH, Ulmer AJ, Heine H: Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1. Eur J Immunol. 2005, 35 (3): 911-921. 10.1002\/eji.200425336.","journal-title":"Eur J Immunol"},{"issue":"44","key":"468_CR22","doi-asserted-by":"publisher","first-page":"42372","DOI":"10.1074\/jbc.M205966200","volume":"277","author":"M Muroi","year":"2002","unstructured":"Muroi M, Ohnishi T, Tanamoto K: Regions of the mouse CD14 molecule required for toll-like receptor 2- and 4-mediated activation of NF-kappa B. J Biol Chem. 2002, 277 (44): 42372-42379. 10.1074\/jbc.M205966200.","journal-title":"J Biol Chem"},{"issue":"16","key":"468_CR23","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1046\/j.1432-1327.2001.02385.x","volume":"268","author":"T Muta","year":"2001","unstructured":"Muta T, Takeshige K: Essential roles of CD14 and lipopolysaccharide-binding protein for activation of toll-like receptor (TLR)2 as well as TLR4 Reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations. Eur J Biochem. 2001, 268 (16): 4580-4589. 10.1046\/j.1432-1327.2001.02385.x.","journal-title":"Eur J Biochem"},{"issue":"5","key":"468_CR24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s004010000326","volume":"101","author":"J Gerber","year":"2001","unstructured":"Gerber J, Raivich G, Wellmer A, Noeske C, Kunst T, Werner A, Bruck W, Nau R: A mouse model of Streptococcus pneumoniae meningitis mimicking several features of human disease. Acta Neuropathol (Berl). 2001, 101 (5): 499-508.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"4","key":"468_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0736-4679(01)00407-3","volume":"21","author":"JR Miner","year":"2001","unstructured":"Miner JR, Heegaard W, Mapes A, Biros M: Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med. 2001, 21 (4): 387-392. 10.1016\/S0736-4679(01)00407-3.","journal-title":"J Emerg Med"},{"issue":"1-2","key":"468_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jneuroim.2004.01.026","volume":"151","author":"DN Meli","year":"2004","unstructured":"Meli DN, Loeffler JM, Baumann P, Neumann U, Buhl T, Leppert D, Leib SL: In pneumococcal meningitis a novel water-soluble inhibitor of matrix metalloproteinases and TNF-alpha converting enzyme attenuates seizures and injury of the cerebral cortex. J Neuroimmunol. 2004, 151 (1-2): 6-11. 10.1016\/j.jneuroim.2004.01.026.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"468_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1128\/CMR.15.1.95-110.2002","volume":"15","author":"R Nau","year":"2002","unstructured":"Nau R, Eiffert H: Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis. Clin Microbiol Rev. 2002, 15 (1): 95-110. 10.1128\/CMR.15.1.95-110.2002.","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"468_CR28","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1086\/315861","volume":"182","author":"KL Orman","year":"2000","unstructured":"Orman KL, English BK: Effects of antibiotic class on the macrophage inflammatory response to Streptococcus pneumoniae. J Infect Dis. 2000, 182 (5): 1561-1565. 10.1086\/315861.","journal-title":"J Infect Dis"},{"issue":"7","key":"468_CR29","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1086\/378238","volume":"188","author":"LJ Moore","year":"2003","unstructured":"Moore LJ, Pridmore AC, Dower SK, Read RC: Penicillin enhances the toll-like receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae. J Infect Dis. 2003, 188 (7): 1040-1048. 10.1086\/378238.","journal-title":"J Infect Dis"},{"key":"468_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.imbio.2005.05.017","volume":"210","author":"H Echchannaoui","year":"2005","unstructured":"Echchannaoui H, Bachmann P, Letiembre M, Espinosa M, Landmann R: Regulation of Streptococcus pneumoniae distribution by Toll-like receptor 2 in vivo. Immunobiology. 2005, 210: 229-236. 10.1016\/j.imbio.2005.05.017.","journal-title":"Immunobiology"},{"issue":"5673","key":"468_CR31","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1126\/science.1096158","volume":"304","author":"JM Blander","year":"2004","unstructured":"Blander JM, Medzhitov R: Regulation of phagosome maturation by signals from toll-like receptors. Science. 2004, 304 (5673): 1014-1018. 10.1126\/science.1096158.","journal-title":"Science"},{"issue":"4","key":"468_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.immuni.2005.09.007","volume":"23","author":"RM Yates","year":"2005","unstructured":"Yates RM, Russell DG: Phagosome maturation proceeds independently of stimulation of toll-like receptors 2 and 4. Immunity. 2005, 23 (4): 409-417. 10.1016\/j.immuni.2005.09.007.","journal-title":"Immunity"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-25.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-7-25\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-25.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T17:41:00Z","timestamp":1683826860000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-7-25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,11]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["468"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-7-25","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,11]]},"assertion":[{"value":"8 July 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"25"}}